Skip to main content
Pradeep Mammen, MD, Cardiology, Kansas City, KS

Pradeep Pa Mammen MD FACC, FAHA, FHFSA

Heart Failure & Transplantation, Cardiovascular Disease Genetics


Professor of Internal Medicine; Alfred W. Harris, MD Professorship in Cardiology; Co-Director: UTSW Wellstone Muscular Dystrophy Reseach Center; Medical Director: Neuromuscular Cardiomyopathy Clinic; Director: Translational Research for the Advanced Heart Failure &Transplant Cardiology Program; Member of the UTSW Heart Failure, Ventricular Assist Devices, & Heart Transplant Program.

Join to View Full Profile
  • 4000 Cambridge StSte G600Kansas City, KS 66160

  • Phone+1 913-588-9600

  • Fax+1 214-648-1450

Dr. Mammen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • I am a clinician-scientist with clinical expertise in advanced heart failure, ventricular assist devices and heart transplantation. From a clinical perspective, I am one of only approximately 1,000 adult cardiologists in the US board certified in advanced heart failure/heart transplantation. I am currently an Associate Professor of Medicine, Co-Director of the UTSW Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center (one of six NIH funded Centers in the country), and the Director for Translational Research for the Advanced Heart Failure and Transplant Cardiology Program at UTSW. Finally, I have developed clinical expertise in the care of patients who develop a familial or genetic form of cardiomyopathy (esp. neuromuscular-associated cardiomyopathies). In 2010, I founded and became the Medical Director of the UTSW Neuromuscular Cardiomyopathy Clinic. This clinic is only one of six adult clinics in the United States exclusively dedicated to addressing the cardiovascular needs of patients with neuromuscular disorders.

    In keeping with my clinical interest in the treatment and management of patients with heart failure, I have developed significant scientific expertise in investigating the molecular mechanisms underlying heart failure and cardiac/skeletal muscle myopathies. In the Fall of 2015, Dr. Eric Olson, Chair of the UTSW Department of Molecular Biology and I became the Co-Directors of the UTSW Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center. The core mission of the Center is to rapidly develop genome editing into a viable and effective therapy for patients with Duchenne muscular dystrophy. In addition, I run a NIH R01-funded molecular laboratory focused on mechanistic studies to enhance our understanding of various signaling pathways that contribute to heart failure and cardiac/skeletal muscle myopathies.

Education & Training

  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterFellowship, Advanced Heart Failure and Transplant Cardiology, 2003 - 2004
  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterPost-Doctoral Fellowship, 2000 - 2004
  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterFellowship, Cardiovascular Disease, 1998 - 2000
  • University of Iowa Hospitals and Clinics
    University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 1995 - 1998
  • University of Wisconsin School of Medicine & Public Health
    University of Wisconsin School of Medicine & Public HealthClass of 1995, MD, Outstanding Medical Student Research Award (1994), Outstanding Leadership and Service Award (1991)
  • University of Pennsylvania
    University of PennsylvaniaB.S.E., Bioengineering/Electrical Engineering, 1987 - 1990

Certifications & Licensure

  • IA State Medical License
    IA State Medical License 1995 - 2026
  • KS State Medical License
    KS State Medical License 2023 - 2026
  • MO State Medical License
    MO State Medical License 2023 - 2026
  • TX State Medical License
    TX State Medical License 1998 - 2026
  • Advanced Heart Failure and Transplant Cardiology
    American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology

Awards, Honors, & Recognition

  • Co-Director: UTSW Wellstone Muscular Dystrophy Specialized Research Center NIH U54/P50 Research Grant: Co-Recipient with Eric N. Olson, PhD
  • Heart Failure Society of America: Fellow Heart Failure Society of America, 2020
  • Recipient of a NIH-NHLBI R01 Research Grant National Institute of Health (NHLBI), 2012-2019
  • Join now to see all

Publications & Presentations

PubMed

Lectures

  • Management of Duchenne muscular dystrophy-associated cardiomyopathy. 
    Action Duchenne International Conference-2015 (London, UK) - 11/6/2015
  • Circulating microRNAs in cardiomyopathy 
    CareDx Inc. (San Francisco, CA) - 10/26/2015
  • Development of atrophic cardiomyopathy in neuromuscular disorders: A novel mode of maladaptive cardiac remodeling. 
    Senator Paul D. Wellstone Muscular Dystrophy Center Network Conference (U. of Washington-Seattle) - 10/14/2015
  • Join now to see all

Authored Content

  • The nuclear envelope protein Net39 is essential for muscle nuclear integrity and chromatin organizationJanuary 2021

Press Mentions

  • First Cardiovascular Gene Therapy Trial in U.S. For People with Duchenne Muscular Dystrophy Begins at KU Medical Center
    First Cardiovascular Gene Therapy Trial in U.S. For People with Duchenne Muscular Dystrophy Begins at KU Medical CenterJuly 18th, 2025
  • Dosing Begins in Gene Therapy Trial for DMD-Linked Heart Disease
    Dosing Begins in Gene Therapy Trial for DMD-Linked Heart DiseaseJuly 17th, 2025
  • Medera and University of Kansas Medical Center Announce First Patient Treated in Pioneering Gene Therapy Trial for Duchenne Muscular Dystrophy Associated Cardiomyopathy
    Medera and University of Kansas Medical Center Announce First Patient Treated in Pioneering Gene Therapy Trial for Duchenne Muscular Dystrophy Associated CardiomyopathyJuly 15th, 2025
  • Join now to see all

Grant Support

  • Development of early metabolic imaging biomarkers for muscular dystrophy and cardiomyopathy in patientsUT SOUTHWESTERN MEDICAL CENTER2024–2028
  • Myoediting of Duchenne Muscular DystrophyUT SOUTHWESTERN MEDICAL CENTER2015–2025
  • Cytoglobin: A Stress-Responsive Hemoprotein Modulating Cardiomyocyte SurvivalNational Heart, Lung, And Blood Institute2012
  • Regulation of tissue hemoglobins in the heart.National Institute of Health (K08 Research Grant; NHLBI)2005–2011
  • Regulation Of Tissue Hemoglobins In The HeartNational Heart, Lung, And Blood Institute2005–2009

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: